Q4 FY2024 · Presentation
EyePoint Pharmaceuticals Inc. - Special Call · 31 pages
Read EyePoint, Inc.'s results firsthand
Preview the first 2 pages of this presentation
Create a free account to start reading
Full documents are included with Professional